326 related articles for article (PubMed ID: 33877518)
21. Programmed death protein 1 is essential for maintaining the anti-inflammatory function of infiltrating regulatory T cells in a murine spinal cord injury model.
He X; Lin S; Yang L; Tan P; Ma P; Qiu P; Zheng C; Zhang X; Kang W; Lin W
J Neuroimmunol; 2021 May; 354():577546. PubMed ID: 33744709
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive insights into the effects and regulatory mechanisms of immune cells expressing programmed death-1/programmed death ligand 1 in solid tumors.
Liu M; Sun Q; Wei F; Ren X
Cancer Biol Med; 2020 Aug; 17(3):626-639. PubMed ID: 32944395
[TBL] [Abstract][Full Text] [Related]
23. Immune Checkpoint Blockade in Breast Cancer Therapy.
Bu X; Yao Y; Li X
Adv Exp Med Biol; 2017; 1026():383-402. PubMed ID: 29282694
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of PD-1 or PD-L1 Inhibitors and Central Nervous System Metastases in Advanced Cancer: A Meta-Analysis.
Peng M; Li S; Xiang H; Huang W; Mao W; Xu D
Curr Cancer Drug Targets; 2021; 21(9):794-803. PubMed ID: 34077347
[TBL] [Abstract][Full Text] [Related]
25. Central Nervous System Germinomas Express Programmed Death Ligand 1.
Wildeman ME; Shepard MJ; Oldfield EH; Lopes MBS
J Neuropathol Exp Neurol; 2018 Apr; 77(4):312-316. PubMed ID: 29415126
[TBL] [Abstract][Full Text] [Related]
26. Perspectives in Pain Research 2014: Neuroinflammation and glial cell activation: The cause of transition from acute to chronic pain?
Cairns BE; Arendt-Nielsen L; Sacerdote P
Scand J Pain; 2015 Jan; 6(1):3-6. PubMed ID: 29911589
[TBL] [Abstract][Full Text] [Related]
27. The role of microglia in central nervous system immunity and glioma immunology.
Yang I; Han SJ; Kaur G; Crane C; Parsa AT
J Clin Neurosci; 2010 Jan; 17(1):6-10. PubMed ID: 19926287
[TBL] [Abstract][Full Text] [Related]
28. Microglia in central nervous system repair after injury.
Jin X; Yamashita T
J Biochem; 2016 May; 159(5):491-6. PubMed ID: 26861995
[TBL] [Abstract][Full Text] [Related]
29. Immunosenescence of microglia and macrophages: impact on the ageing central nervous system.
Rawji KS; Mishra MK; Michaels NJ; Rivest S; Stys PK; Yong VW
Brain; 2016 Mar; 139(Pt 3):653-61. PubMed ID: 26912633
[TBL] [Abstract][Full Text] [Related]
30. PD-1 Regulates GABAergic Neurotransmission and GABA-Mediated Analgesia and Anesthesia.
Jiang C; Wang Z; Donnelly CR; Wang K; Andriessen AS; Tao X; Matsuda M; Zhao J; Ji RR
iScience; 2020 Oct; 23(10):101570. PubMed ID: 33083737
[TBL] [Abstract][Full Text] [Related]
31. Effects of combined chemotherapy and anti-programmed cell death protein 1 treatment on peripheral neuropathy and neuroinflammation in mice.
Livni L; Keating BA; Fiore NT; Lees JG; Goldstein D; Moalem-Taylor G
Pain; 2022 Jan; 163(1):110-124. PubMed ID: 34224494
[TBL] [Abstract][Full Text] [Related]
32. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.
Koning N; Swaab DF; Hoek RM; Huitinga I
J Neuropathol Exp Neurol; 2009 Feb; 68(2):159-67. PubMed ID: 19151626
[TBL] [Abstract][Full Text] [Related]
33. PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE.
Schreiner B; Bailey SL; Shin T; Chen L; Miller SD
Eur J Immunol; 2008 Oct; 38(10):2706-17. PubMed ID: 18825752
[TBL] [Abstract][Full Text] [Related]
34. RAM-589.555 favors neuroprotective and anti-inflammatory profile of CNS-resident glial cells in acute relapse EAE affected mice.
Zilkha-Falb R; Rachutin-Zalogin T; Cleaver L; Gurevich M; Achiron A
J Neuroinflammation; 2020 Oct; 17(1):313. PubMed ID: 33081798
[TBL] [Abstract][Full Text] [Related]
35. Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases.
Li L; Acioglu C; Heary RF; Elkabes S
Brain Behav Immun; 2021 Jan; 91():740-755. PubMed ID: 33039660
[TBL] [Abstract][Full Text] [Related]
36. Microglia in antiviral immunity of the brain and spinal cord.
O'Brien CA; Bennett FC; Bennett ML
Semin Immunol; 2022 Mar; 60():101650. PubMed ID: 36099864
[TBL] [Abstract][Full Text] [Related]
37. Cardiolipin in Central Nervous System Physiology and Pathology.
Pointer CB; Klegeris A
Cell Mol Neurobiol; 2017 Oct; 37(7):1161-1172. PubMed ID: 28039536
[TBL] [Abstract][Full Text] [Related]
38. PD-L1 and PD-1 expression in pediatric central nervous system germ cell tumors.
Woods JK; Lidov HG; Ligon KL; Santagata S; Chi SN; Yeo KK; Alexandrescu S
Mod Pathol; 2022 Dec; 35(12):1770-1774. PubMed ID: 36057740
[TBL] [Abstract][Full Text] [Related]
39. Programmed death-1 immune checkpoint blockade in the treatment of hematological malignancies.
Tsirigotis P; Savani BN; Nagler A
Ann Med; 2016 Sep; 48(6):428-439. PubMed ID: 27224873
[TBL] [Abstract][Full Text] [Related]
40. Traditional Treatment Approaches and Role of Immunotherapy in Lung Malignancy and Mesothelioma.
Tamanna MT; Egbune C
Cancer Treat Res; 2023; 185():79-89. PubMed ID: 37306905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
